209342-41-6

• 常用中文名：非那沙星
• 常用英文名：Finafloxacin Hydrochloride
• CAS号：209342-41-6
• 分子式：C₂₀H₂₀ClFN₄O₄
• 分子量：434.85
• 相关类别： 原料药 人工合成抗感染类药 喹诺酮类药
• 发布时间：2017-10-14 09:52:54
• 更新时间：2026-07-27 19:32:49
• Finafloxacin 是氟喹诺酮抗微生物剂, 在微酸环境中达到最佳功效。

名称

• 中文名: 非那沙星
• 英文名: 7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid,hydrochloride
• 中文别名: 非那沙星盐酸盐; 8-氰基-1-环丙基-6-氟-7-((4AS,7AS)-六氢吡咯并[3,4-B][1,4]恶嗪-6(2H)-基)-4-氧代-1,4-二氢喹啉-3-羧酸盐酸盐; 盐酸非那沙星; 非那沙星-D4 HCL
• 英文别名: 7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-cboxylic acid,hydrochloride; 3-Quinolinecarboxylic acid,8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-1,4-dihydro-4-oxo-,monohydrochloride; 8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-cboxylic acid hydrochloride; BAY-35-3377; 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-Quinolinecboxylic acid hydrochloride (1:1); 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; QCR-31; BY-377; Finafloxacin hydrochloride; 8-cyano-1-cyclopropyl-6-fluoro-7; 3-Quinolinecboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-, Monohydrochloride (9CI); 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-quinolinecboxylic Acid Hydrochloride; Finafloxacin-d4 HCl; 8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo; 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-quinolinecboxylic acid monohydrochloride; FINAFLOXACIN HCL; 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-quinolin-3-cboxylic acid HCl; 3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-, hydrochloride (1:1); 3-Quinolinecboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-, hydrochloride (1:1); Finafloxacin Hydrochloride //BP; 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrochloride (1:1); Finafloxacin hydrochloride salt; 4-oxoquinoline-3-cboxylic acid,hydrochloride

物化性质

• 分子式: C₂₀H₂₀ClFN₄O₄
• 分子量: 434.85
• 精确质量: 434.115723
• PSA: 107.59000
• LogP: 2.41818
• 蒸汽压: 9.03E-20mmHg at 25°C
• 储存条件: -20°C，密闭，干燥

生物活性

• 描述: Finafloxacin 是氟喹诺酮抗微生物剂, 在微酸环境中达到最佳功效。
• 相关类别:
  研究领域 >> 感染
  信号通路 >> 抗感染 >> 细菌